UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035213
Receipt number R000039889
Scientific Title Real-time Artificial Intelligence Aided Diagnosis of Colorectal Polyps during Colonoscopy -a Multicenter Clinical Trial with the EndoBRAIN Technology-
Date of disclosure of the study information 2019/04/08
Last modified on 2022/01/26 07:17:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Real-time Artificial Intelligence Aided Diagnosis of Colorectal Polyps during Colonoscopy
-a Multicenter Clinical Trial with the EndoBRAIN Technology-

Acronym

EndoBRAIN international

Scientific Title

Real-time Artificial Intelligence Aided Diagnosis of Colorectal Polyps during Colonoscopy
-a Multicenter Clinical Trial with the EndoBRAIN Technology-

Scientific Title:Acronym

EndoBRAIN international

Region

Japan Europe


Condition

Condition

Diminutive rectosigmoid polyps

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This international multicenter accuracy trial investigates the diagnostic performance of the real-time artificial intelligence system (EndoBRAIN, Cybernet Systems, Corp. Tokyo) for diagnosis of colorectal polyps in real-World colonoscopy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To compare the sensitivity of identifying diminutive colorectal polyps as adenomas during colonoscopy with the combination of visual inspection and the use of the EndoBRAIN technology to visual inspection alone.

Key secondary outcomes

1. To compare the specificity of identifying diminutive colorectal polyps as adenomas during colonoscopy with the combination of visual inspection and the use of the EndoBRAIN CAD technology to visual inspection alone.
2. To estimate the sensitivity, specificity, positive predictive value, and negative predictive value of the combination of visual inspection and the use of the EndoBRAIN CAD technology
3. To assess whether the diagnostic performance of the combination of visual inspection and the use of the EndoBRAIN CAD technology of endoscopists meets the PIVI-1 and PIVI-2 guideline recommendations for diagnostic performance of the American Society of Gastrointestinal Endoscopy (ASGE)12: >90% accuracy in predicting post-polypectomy surveillance intervals based on optical biopsy with high confidence (PIVI-1*); >90% NPV in identifying rectosigmoid diminutive adenomas based on optical biopsy with high confidence (PIVI-2)6.
4. To estimate the percentage of diminutive colorectal polyps from which endocytoscopic images can be successfully captured (acquisition rate).
5. To estimate the rate of high-confidence diagnosis with EndoBRAIN as compared to visual polyp inspection alone.
6. To evaluate the colonoscopy performance with an endocytoscope including the EndoBRAIN device with regard to cecal intubation rate, insertion time, and complications.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Diagnosis using EndoBRAIN.
(The present study does not require additional invasive interventions as compared to clinical practice. )

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Individuals 18 years or older who are scheduled for screening, surveillance, diagnostic, or therapeutic colonoscopy at the trial centres with diminutive rectosigmoid polyps (<=5mm).

Key exclusion criteria

1. Diminutive polyps with known histology
2. Inflammatory bowel disease
3. Polyposis syndrome (e.g., familial adenomatous polyposis, serrated polyposis)
4. History of chemotherapy or radiation therapy for colorectal lesions
5. Inability to undergo polypectomy (e.g. intake of anticoagulants, comorbidities, or patient refusal)
6. Pregnancy

Target sample size

345


Research contact person

Name of lead principal investigator

1st name Oyvind Holme; Michael Bretthauer;Yuichi Mori (PIs)
Middle name
Last name Amyn Haji; Shin-ei Kudo (co-PIs)

Organization

Oslo University Hospital/University of Oslo, Oslo (OH; MB)
Showa University Northern Yokohama Hospital/Showa University, Tokyo (YM; SK)
King's college hospital, London (AH)

Division name

Clinical Effectiveness Research Group(OH; MB); Digestive Disease Center (YM, SK); Endoscopy & Colorectal Surgery (AH)

Zip code

x

Address

Sognsvannsveien 21 0372 Oslo (OH; MB); 35-1, Chigasaki-tyuo, Tsuzuki-ku, Yokohama (YM, SK); Denmark Hill, London (AH); Denmark Hill, London

TEL

+47-22850550(+81-459497000)(+44-2032999000)

Email

oyvind.holme@medisin.uio.no


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Mori

Organization

Showa University Northern Yokohama Hospital, Yokohama

Division name

Digestive Disease Center

Zip code

2248503

Address

35-1, Chigasaki-tyuo, Tsuzuki-ku

TEL

+81-45-949-7000

Homepage URL


Email

ibusiginjp@gmail.com


Sponsor or person

Institute

Oslo University; Showa University; King's college

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

Olympus Corp., Tokyo (to Oslo Univ.)


IRB Contact (For public release)

Organization

Showa University Northern Yokohama Hospital; Regonale Komiteer For Medisinsk Og Helsefaglig Forskningsetikk

Address

35-1, Chigasaki-tyuo, Tsuzuki-ku, Yokohama; Gullhaugveien 1-3, 0484 Oslo

Tel

+81459497000; +4722857547

Email

irb02syh@ofc.showa-u.ac.jp post@helseforskning.etikkom.no


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Vestre Viken Baerum Hospital
Showa Univeristy Northern Yokohama Hospital
King's College Hospital


Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 08 Day


Related information

URL releasing protocol

NA

Publication of results

Unpublished


Result

URL related to results and publications

NA

Number of participants that the trial has enrolled

1242

Results

To be disclosed after publication.

Results date posted

2022 Year 01 Month 26 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

To be disclosed after publication.

Participant flow

To be disclosed after publication.

Adverse events

To be disclosed after publication.

Outcome measures

To be disclosed after publication.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 12 Month 03 Day

Date of IRB

2018 Year 12 Month 03 Day

Anticipated trial start date

2019 Year 04 Month 08 Day

Last follow-up date

2021 Year 05 Month 05 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The target sample size (N=345) is the number of diminutive rectosigmoid adenomas detected during the study(not the number of the recruited patients)

In this study, patients and endoscopists are not blinded to the intervention (i.e., use of EndoBRAIN), however pathologists are blinded to the optical diagnosis made by the endoscopists.


Management information

Registered date

2018 Year 12 Month 11 Day

Last modified on

2022 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039889


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name